Creatine for women: what the research actually shows

There is a version of this article that opens by telling you creatine is not just for bodybuilders. That version assumes you once believed it was and needs correcting, and for most women reading this, that is not what happened at all. You did not dismiss creatine. You were never in the room when it was discussed.

The reason is ordinary. Creatine was first studied seriously in sport, in the late eighties and nineties, so sports nutrition companies got there first. They built the tubs, the language and the shelf position around the customer they already had. Then, over the last fifteen years, the research quietly moved. It went into ageing, into bone, into memory, into women. The marketing never followed it.

So this is not a correction. It is a set of findings that were published while the category was looking somewhere else.

In 2021 a group of researchers published a review of creatine across the whole of a woman's life, from adolescence through to post-menopause. The finding that anchors the rest of it is simple and, once you have heard it, hard to unhear: women carry roughly 70 to 80 per cent lower creatine stores than men before supplementing.

Two things follow from it. The first is that supplementing does more work in a body that started further from full, which is a large part of why the newer research has concentrated here. The second is less comfortable: dietary creatine comes almost entirely from red meat and fish, so anyone eating less of those is topping up less. Your body still makes about a gram a day regardless, but the rest is down to what is on the plate, the same way diet sets your baseline for most nutrients before a supplement gets involved.

None of this means women should take a larger serving. Dosing follows bodyweight, not sex, so a 58kg woman takes less than a 90kg man. The store is the thing that differs, not the dose.

From roughly the fourth decade onward, lean tissue starts going the other way, and it accelerates after menopause. That is the context for the muscle research, and it is why the acquisition framing you see on creatine tubs is the wrong one here. Nobody in these trials was trying to build a body. They were trying to stop losing one.

A 2017 meta-analysis pooled 22 randomised controlled trials covering 721 older adults with mean ages between 57 and 70. All of them were doing resistance training. The groups also taking creatine finished with 1.37kg more lean tissue than the groups training on placebo, and gained more strength on chest press and leg press.

Read that number the way the researchers did. They open the paper on functional impairment, not on muscle size. Lean tissue mass is simply how they measured the thing they actually cared about, which is whether people could still do what they wanted to do. In a 25-year-old, 1.37kg is a gain. At 62, it is several years of decline held off.

The condition attached to it is not optional. Every trial in that analysis involved resistance training. Creatine supports what you do; it does not do it for you, and an article that leaves the training out is selling you something.

Most supplement trials run for eight or twelve weeks, which is long enough to measure a muscle and far too short to measure a bone. There is one notable exception in the creatine literature and it is worth knowing about.

Seventy adults with a mean age of 58 took either creatine at 0.1g per kilogram of bodyweight or a placebo, while doing supervised whole-body resistance training three days a week for a full year. At the end of it, bone area at the distal tibia and the tibial shaft was maintained or increased in the creatine group, in a comparison where the placebo group lost area. Muscle density in the lower leg increased as well.

That is one trial. It is not a claim that creatine builds bone, and it is certainly not a treatment for anything. What it is, is a reason to take the resistance training part seriously, because the training is doing the work and the creatine is supporting it.

A 2023 review in Nutrition Reviews pooled eight randomised trials of creatine and memory in healthy people. Memory improved against placebo overall. The part that matters is what happened when the researchers split the results by age.

In participants aged 66 to 76, the effect was large. In participants aged 11 to 31, it was indistinguishable from nothing. Dose made no difference to the finding. Duration made no difference. Sex made no difference either, and that is worth saying plainly rather than quietly leaving out: this is not a female-specific effect. It is an age-specific one, and it happens to sit exactly where the word that will not come starts to be an experience rather than a joke.

A larger 2024 meta-analysis of 16 trials found the same thing for memory, plus effects on attention time and processing speed. It also found no significant improvement in overall cognitive function, and none in executive function. That boundary is the honest one and we are not going to walk past it. Creatine is not a general-purpose sharpener. The evidence points at specific measures and then stops.

Two trials looked at what happens to cognitive performance when people are short of sleep. One gave 20g a day for a week before 24 hours of sleep deprivation and found less decline in reaction time, balance and mood. A 2024 trial used a single large dose during about 21 hours without sleep and measured both better cognitive performance and changes in the brain's high-energy phosphates.

With that stated, the relevance to a lot of women in their forties and fifties is obvious enough not to labour. Sleep gets less reliable in the years around menopause, and the days that follow a bad night are the ones where everything feels harder. What the research supports is a body that copes slightly better with that, not a body that stops having bad nights.

This is where a lot of supplement writing goes badly wrong, so here is the whole of the evidence, in order.

The 2021 lifespan review reported benefits for strength before menopause, benefits for muscle size and function after it, favourable effects on bone when creatine was paired with resistance training, and safety comparable to placebo throughout. The authors also note that oestrogen influences creatine metabolism, which is part of why they treat the years around menopause as a period of particular interest.

That is the list. Everything else you may have seen attached to creatine and menopause is not in the evidence. It does not affect hormones. It is not a treatment for menopause or for any symptom of it. It has nothing to say about hot flushes. And most of the post-menopausal research is still small, which is a description of where the science currently is rather than a criticism of it.

What the review supports is narrower and more useful: muscle, bone and everyday function are the things most affected by the transition, and they are also the three things creatine plus resistance training has the best evidence behind.

It will not make you bulky. Building visible muscle takes years of hard progressive training and a great deal of food. The trials above measured lean tissue held or slowly regained in people who were otherwise losing it, which is a different outcome entirely.

It will not stop the scale moving early on. Creatine draws a little water into muscle cells, and that can read as one to two kilograms in the first few weeks. It is water inside the muscle rather than fat, it is part of how the mechanism works, and it settles. Pretending otherwise would be the easy version of this paragraph and the wrong one.

It will not do anything you can feel on day one. Creatine is not a stimulant. It fills a store over three to four weeks, and nothing much happening in week one is exactly what that looks like.

It will not replace the training. Every muscle and bone finding on this page came from a trial where people were lifting something. If resistance training is not currently part of your week, that is the higher-value change, and creatine is the thing that goes alongside it.

Five grams a day is the standard serving and a sensible default. The more useful anchor is roughly 0.1g per kilogram of bodyweight, which is about 6g for a 60kg adult. It is the same bodyweight logic we apply to magnesium dosing. Loading is optional and mostly a way of getting there in one week instead of three or four.

Timeframes matter more than precision here. The muscle trials ran for months. The bone trial ran for a year. If you are going to judge it, judge it at three months, not at three days. The full version, including what to adjust for and the habits that make a measurable difference, is in how to get the most from your creatine.

The research gap has an equivalent on the shelf, and it is the reason Biosphere made a creatine at all. Here is our co-founder Andrew on it.

The point is not that a flavour is a breakthrough. It is that an unflavoured tub is a decision about who the customer is, and for thirty years that decision quietly excluded most of the people the research has since been done on.